168 related articles for article (PubMed ID: 24831325)
1. Topical pharmacotherapy for skin cancer: part II. Clinical applications.
Micali G; Lacarrubba F; Nasca MR; Ferraro S; Schwartz RA
J Am Acad Dermatol; 2014 Jun; 70(6):979.e1-12; quiz 9912. PubMed ID: 24831325
[TBL] [Abstract][Full Text] [Related]
2. Topical pharmacotherapy for skin cancer: part I. Pharmacology.
Micali G; Lacarrubba F; Nasca MR; Schwartz RA
J Am Acad Dermatol; 2014 Jun; 70(6):965.e1-12; quiz 977-8. PubMed ID: 24831324
[TBL] [Abstract][Full Text] [Related]
3. Treating skin cancer with topical cream.
Micali G; Lacarrubba F; Dinotta F; Massimino D; Nasca MR
Expert Opin Pharmacother; 2010 Jun; 11(9):1515-27. PubMed ID: 20408746
[TBL] [Abstract][Full Text] [Related]
4. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
5. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
6. Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience.
Wang XL; Wang HW; Guo MX; Xu SZ
Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):127-33. PubMed ID: 19356643
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Akkilic-Materna M; Massone C; Komericki P
Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
[TBL] [Abstract][Full Text] [Related]
8. Ingenol mebutate: an introduction.
Fallen RS; Gooderham M
Skin Therapy Lett; 2012 Feb; 17(2):1-3. PubMed ID: 22358305
[TBL] [Abstract][Full Text] [Related]
9. Topical treatments for skin cancer.
Cullen JK; Simmons JL; Parsons PG; Boyle GM
Adv Drug Deliv Rev; 2020 Jan; 153():54-64. PubMed ID: 31705912
[TBL] [Abstract][Full Text] [Related]
10. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma.
Newman MD; Weinberg JM
Cutis; 2007 Apr; 79(4 Suppl):18-28. PubMed ID: 17508492
[TBL] [Abstract][Full Text] [Related]
11. Medical approaches to non-melanoma skin cancer.
Micali G; Lacarrubba F; Bhatt K; Nasca MR
Expert Rev Anticancer Ther; 2013 Dec; 13(12):1409-21. PubMed ID: 24236820
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
Knackstedt TJ; Quitadamo M
Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
[TBL] [Abstract][Full Text] [Related]
14. Local reactions to imiquimod in the treatment of basal cell carcinoma.
Tandon Y; Brodell RT
Dermatol Online J; 2012 Sep; 18(9):1. PubMed ID: 23031368
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Moore AY
J Dermatolog Treat; 2009; 20(6):328-35. PubMed ID: 19954388
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
[No Abstract] [Full Text] [Related]
17. New therapeutic options for actinic keratosis and basal cell carcinoma.
Sligh JE
Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
[TBL] [Abstract][Full Text] [Related]
18. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
19. [Imiquimod cream. A cream to use with precaution].
Taeron C
Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
[No Abstract] [Full Text] [Related]
20. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.
Siller G; Rosen R; Freeman M; Welburn P; Katsamas J; Ogbourne SM
Australas J Dermatol; 2010 May; 51(2):99-105. PubMed ID: 20546215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
